Medical Doctor Program year 2022 Source: CMS Open Payments, 2026 publication

Zachary Finley

Hand Surgery Rapid City, SD Medical Doctor

NPI 1386099760 CMS profile 11319097

7220 Mount Rushmore Rd, Rapid City, SD 57702

Open in the dashboard

General payments

$2,322

23 records reported · program year 2022

Research payments

$0

Paid to them · None reported · program year 2022

Ownership & investment interest

$0

None reported

Through program year 2022, Zachary Finley of Rapid City, SD is reported in the CMS Open Payments database as having received $2,322 across 23 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 50th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2022 General $2,322 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Finley
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Zachary Finley were reported at $0. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Zachary Finley Hand Surgery median Middle half National median
2019 $0 $383 $106–$1,905 $163
2020 $0 $172 $51–$1,268 $114
2021 $0 $263 $71–$1,591 $132
2022 $2,322 $336 $87–$1,938 $149
2023 $0 $233 $81–$1,114 $160
2024 $0 $258 $88–$1,203 $164
2025 $0 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program year 2022
  1. Stryker Corporation $1,733 19 payments
  2. TriMed, Inc. $350 1 payment
  3. Medacta USA, Inc. $125 1 payment
  4. Checkpoint Surgical, Inc $97 1 payment
  5. Endo Pharmaceuticals Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program year 2022
  1. Travel and Lodging $1,675 11 payments
  2. Food and Beverage $647 12 payments
Products named General payments · program year 2022
  1. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $1,536 15 payments
  2. PRIMARY SHOULDER $125 1 payment
  3. Checkpoint Stimulators $97 1 payment
  4. VARIAX $88 1 payment
  5. TORNIER PERFORM REVERSED AUGMENTED GLENOID $82 2 payments
  6. COBRA $26 1 payment
  7. XIAFLEX $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

129

Median for Hand Surgery: 118

Drug cost

$494

Median for Hand Surgery: $615

Branded share of claims

42.6%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 55 $394
Tramadol Hcl Generic 60 $84
Meloxicam Generic 14 $15

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$133,986

Of which drugs: $1,745

Medicare patients

344

Average age 72

Services billed

1,454

204 women, 140 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 67%
High blood pressure 66%
Diabetes 24%
Osteoporosis 19%
Ischemic heart disease 18%
Depression 17%
COPD 13%
Chronic kidney disease 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 110 326 $1,737

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

23 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record